시간 외 거래: 2.30 0.010 +0.44%

Corvus Pharmaceuticals Inc (CRVS)

Corvus Pharmaceuticals Inc 주식(CRVS)의 최신 뉴스

Corvus Pharmaceuticals Inc (CRVS)

Corvus Pharmaceuticals Inc 주식(CRVS)의 최신 뉴스

Understanding the Risks of Investing in Corvus Pharmaceuticals Inc (CRVS) – Knox Daily - Knox Daily

Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Crosses Above 50-Day Moving Average of $1.77 - MarketBeat

Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) market cap surged US$9.8m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St

Co-Founder Richard Miller Just Bought 8.5% More Shares In Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) - Yahoo News Australia

Corvus Pharmaceuticals director acquires $4.9m in company warrants - Investing.com

OrbiMed Advisors buys $4.9m in Corvus Pharmaceuticals warrants - Investing.com Nigeria

Richard A. Md Miller Purchases 577634 Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Stock - Defense World

Corvus Pharmaceuticals (NASDAQ:CRVS) PT Raised to $8.00 at Oppenheimer - Defense World

William Benton Jones Purchases 20,000 Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Stock - MarketBeat

Corvus Pharmaceuticals executive buys $34,624 in company stock By Investing.com - Investing.com

Corvus Pharmaceuticals (NASDAQ:CRVS) Price Target Raised to $8.00 - MarketBeat

Corvus Pharmaceuticals CEO buys $1m in company shares - Investing.com

Earnings call: Corvus Pharmaceuticals Q1 2024 financial results and trials update - Investing.com

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript - Yahoo Finance

A significant driver of top-line growth: Corvus Pharmaceuticals Inc (CRVS) – Sete News - SETE News

William Benton Jones Purchases 20,000 Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Stock - MarketBeat

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript - Insider Monkey

Corvus Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation (NASDAQ:CRVS) - Seeking Alpha

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results - 06.05.2024 - wallstreet:online

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results | Daily - Daily Guardian Canada

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results

Corvus Pharmaceuticals Inc (NASDAQ:CRVS): It's all about numbers this morning – US Post News - US Post News

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results - Yahoo Finance

What Type Of Shareholders Make Up Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) Share Registry? - Yahoo Movies Canada

What Type Of Shareholders Make Up Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) Share Registry? - Yahoo Movies Canada

Corvus Pharmaceuticals (CRVS) Set to Announce Quarterly Earnings on Monday - Defense World

Corvus Pharmaceuticals (CRVS) Set to Announce Quarterly Earnings on Monday - Defense World

Corvus Pharmaceuticals (CRVS) to Release Earnings on Monday - MarketBeat

Corvus Pharmaceuticals (CRVS) to Release Earnings on Monday - MarketBeat

Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024 - WICZ

Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024

Corvus Pharmaceuticals raises $30.6 million in stock sale By Investing.com - Investing.com UK

Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering

Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024 - Investing.com India

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Short Interest Update - Defense World

Here's Why Corvus (CRVS) is Poised for a Turnaround After Losing -25% in 4 Weeks

Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

CRVS Stock Quote Price and Forecast - CNN

Down -18.35% in 4 Weeks, Here's Why Corvus (CRVS) Looks Ripe for a Turnaround

Corvus (CRVS) Upgraded to Buy: What Does It Mean for the Stock?

Corvus Pharmaceuticals: Insider Ownership Raises Power Concentration Concerns - TipRanks.com - TipRanks

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Corvus: Q4 Earnings Snapshot - Quartz

Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024

We Think Corvus Pharmaceuticals (NASDAQ:CRVS) Needs To Drive Business Growth Carefully - Yahoo Finance

Will Corvus Pharmaceuticals (NASDAQ:CRVS) Spend Its Cash Wisely? - Simply Wall St

Soquelitinib Receives FDA Orphan Drug Designation FDA for T-Cell Lymphoma - www.oncnursingnews.com/

Corvus' (CRVS) Lymphoma Drug Gets Orphan Status, Stock Up

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases

Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune ... - GlobeNewswire

CRVS과 유사한 종목